Gurugram: In a major step toward advancing cardiac treatment in India, Medanta – The Medicity has launched its Advanced Surgical Heart Failure Clinic, a specialized centre focused on the diagnosis, surgical treatment, and rehabilitation of patients suffering from severe and end-stage heart failure.
A Multidisciplinary Approach to Heart Failure Treatment
The newly launched clinic brings together a team of cardiac surgeons, heart failure specialists, interventional cardiologists, and rehabilitation experts, offering a fully integrated and evidence-based care model.
Equipped with cutting-edge technologies such as cardiopulmonary exercise testing (CPET), right heart catheterization, genetic and biopsy testing, and comprehensive pre- and post-transplant rehabilitation, the clinic is designed to go beyond conventional drug-based management.
It provides advanced therapies, including mechanical circulatory support devices (LVAD, RVAD, BiVAD, ECMO), high-risk and redo cardiac surgeries, and heart and lung transplant readiness programs — aiming to enhance survival rates and improve long-term patient outcomes.
Focus on Early Detection and Precision-Driven Cardiac Care
Medanta’s new facility emphasizes early diagnosis and timely surgical intervention, helping patients with LVAD or transplant planning and bridge-to-transplant or destination therapy approaches.
The clinic also offers comprehensive counselling and lifestyle education for patients and families, along with financial guidance and long-term care planning, ensuring a truly holistic recovery process.
Addressing India’s Heart Failure Crisis
“Advanced-stage heart failure remains a critical healthcare challenge in India, with one-year mortality rates as high as 23.7%,” said Dr. Anil Bhan, Chairman – Cardiac Surgery, Heart Transplant & Cardiac Care, Medanta Gurugram.
He added, “Data from over 10,000 heart failure patients shows ischemic heart disease causes a 21.1% one-year mortality, while dilated cardiomyopathy accounts for 23.7%. Rheumatic heart disease is the third major contributor. Our new clinic will provide advanced surgical therapies like LVADs, ECMO, and heart transplantation, which can dramatically improve survival and restore quality of life for patients with advanced cardiac dysfunction.”
Bridging the Gap in Advanced Cardiac Treatment
Echoing this commitment, Dr. Naresh Trehan, Chairman and Managing Director, Medanta, said, “Heart failure represents one of the most pressing challenges in modern medicine. For patients with end-stage or complex heart failure, conventional medical management alone is often not enough. Our Advanced Surgical Heart Failure Clinic is designed to bridge this gap, offering advanced surgical solutions and a chance for a better quality of life.”
Who Should Seek Advanced Evaluation
According to Medanta, patients meeting the “I NEED HELP” criteria — such as those requiring IV inotropes, experiencing NYHA Class IIIB/IV symptoms, end-organ dysfunction, recurrent hospitalizations, low ejection fraction, or therapy intolerance — should be referred for advanced heart failure evaluation.
Strengthening Medanta’s Leadership in Cardiac Care
With the launch of the Advanced Surgical Heart Failure Clinic, Medanta reinforces its position as a leader in comprehensive cardiovascular care. The initiative underscores the hospital’s commitment to combining innovation, precision medicine, and multidisciplinary expertise to deliver life-saving cardiac treatments in India.